FIELD: medicine, pharmacology. SUBSTANCE: composition has the following components, %: lysine baicaleinate, 15-25; propylene glycol, 35-45; and distilled water, the balance. EFFECT: enhanced effectiveness of treatment and functional activity, decreased by-side effects of cytostatics, broadened arsenal of agents. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT AGAINST INFECTIONS CAUSED BY LISTERIA | 1994 |
|
RU2079302C1 |
HEME STIMULATING AGENT | 1994 |
|
RU2094045C1 |
MEDICINAL AGENT STIMULATING ERYTHROIDE HEMOPOIESIS GERM AT CYTOSTATIC MYELODEPRESSION STATES | 1992 |
|
RU2061475C1 |
MEDICINAL AGENT STIMULATING ERYTHROID AND GRANULOCYTE ERYTHROPOIESIS STEMS AT CYTOSTATIC MYELODEPRESSIONS | 1993 |
|
RU2083201C1 |
METHOD FOR MORPHOLOGICALLY EVALUATING DEAD CELL NUMBER IN APOPTOSIS CASES | 1999 |
|
RU2157999C1 |
ANTIMUTAGENIC AGENT | 2000 |
|
RU2189232C2 |
METHOD OF GRANULOCYTOPOIESIS DEPRESSION CORRECTION IN CYTOSTATIC ACTION | 2008 |
|
RU2366422C1 |
NOOTROPIC AND AGAPTOGENIC AGENT AND FOOD ADDITIVE ON ITS BASE | 1999 |
|
RU2186578C2 |
MEDICINE CAPABLE OF SELECTIVELY STIMULATING GRANULO-MONOCYTOPOIESIS IN CASE OF HYPOPLASIA OF MEDULLARY HEMOPOIESIS TRIGGERED BY CYTOSTATIC | 1988 |
|
RU2020936C1 |
PURGATIVE DRUG | 1998 |
|
RU2144823C1 |
Authors
Dates
1997-12-10—Published
1994-03-05—Filed